Analyse @YaleCancer's tweets
@YaleCancer
| 15,260 followers
Research shared by @Annechiangmd #ASCO23 demonstrates clinical activity using ipilimumab/Nivolumab, a dual checkpoint inhibitor blockade, in patients with Small Cell Lung Cancer #SCLC #lcsm @SmilowCancer @YaleMed @YaleThoracic @YNHH https://t.co/1xiZxCUCkm